Responses

PDF

Psychosis patients refusing antipsychotic medicine could benefit from CBT in terms of both symptom reduction and social functioning
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]
Publication Date - String

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    CBT for Psychosis: the devil is in the detail

    Dear Editor,

    Dr Lecomte provides a strongly endorsing overview of Morrison et als (2014) recent trial of CBT for psychosis in patients who refuse medication. However, her synopsis and associated implications are not as unequivocal nor as supportive of CBT as Dr Lecomte suggests.

    1)First, no significant CBT vs control group differences emerged on any of Morrison et als primary symptom measures (overall, pos...

    Show More
    Conflict of Interest:
    None declared.